1164 related articles for article (PubMed ID: 23714657)
21. Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay.
Kang JS; Choi JS; Kim WK; Lee YJ; Park JW
Reprod Biol Endocrinol; 2014 Nov; 12():102. PubMed ID: 25371027
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds.
Kitamura S; Suzuki T; Sanoh S; Kohta R; Jinno N; Sugihara K; Yoshihara S; Fujimoto N; Watanabe H; Ohta S
Toxicol Sci; 2005 Apr; 84(2):249-59. PubMed ID: 15635150
[TBL] [Abstract][Full Text] [Related]
23. Endocrine activity of alternatives to BPA found in thermal paper in Switzerland.
Goldinger DM; Demierre AL; Zoller O; Rupp H; Reinhard H; Magnin R; Becker TW; Bourqui-Pittet M
Regul Toxicol Pharmacol; 2015 Apr; 71(3):453-62. PubMed ID: 25579646
[TBL] [Abstract][Full Text] [Related]
24. Effect of selected bisphenol derivatives on nuclear receptor expression in ovarian cell line COV434.
Mlynarcikova AB; Scsukova S
Endocr Regul; 2020 Nov; 54(4):275-283. PubMed ID: 33885253
[No Abstract] [Full Text] [Related]
25. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
Conroy-Ben O; Garcia I; Teske SS
Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
[TBL] [Abstract][Full Text] [Related]
26. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes.
Delfosse V; Grimaldi M; Pons JL; Boulahtouf A; le Maire A; Cavailles V; Labesse G; Bourguet W; Balaguer P
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14930-5. PubMed ID: 22927406
[TBL] [Abstract][Full Text] [Related]
27. Nuclear receptor profiling of bisphenol-A and its halogenated analogues.
Delfosse V; Grimaldi M; le Maire A; Bourguet W; Balaguer P
Vitam Horm; 2014; 94():229-51. PubMed ID: 24388193
[TBL] [Abstract][Full Text] [Related]
28. Parallel assessment of the effects of bisphenol A and several of its analogs on the adult human testis.
Desdoits-Lethimonier C; Lesné L; Gaudriault P; Zalko D; Antignac JP; Deceuninck Y; Platel C; Dejucq-Rainsford N; Mazaud-Guittot S; Jégou B
Hum Reprod; 2017 Jul; 32(7):1465-1473. PubMed ID: 28482050
[TBL] [Abstract][Full Text] [Related]
29. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.
Okada H; Tokunaga T; Liu X; Takayanagi S; Matsushima A; Shimohigashi Y
Environ Health Perspect; 2008 Jan; 116(1):32-8. PubMed ID: 18197296
[TBL] [Abstract][Full Text] [Related]
30. Biomonitoring of occupational exposure to bisphenol A, bisphenol S and bisphenol F: A systematic review.
Bousoumah R; Leso V; Iavicoli I; Huuskonen P; Viegas S; Porras SP; Santonen T; Frery N; Robert A; Ndaw S
Sci Total Environ; 2021 Aug; 783():146905. PubMed ID: 33865140
[TBL] [Abstract][Full Text] [Related]
31. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound.
Eladak S; Grisin T; Moison D; Guerquin MJ; N'Tumba-Byn T; Pozzi-Gaudin S; Benachi A; Livera G; Rouiller-Fabre V; Habert R
Fertil Steril; 2015 Jan; 103(1):11-21. PubMed ID: 25475787
[TBL] [Abstract][Full Text] [Related]
32. Computer-aided identification of novel protein targets of bisphenol A.
Montes-Grajales D; Olivero-Verbel J
Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A.
Riu A; Grimaldi M; le Maire A; Bey G; Phillips K; Boulahtouf A; Perdu E; Zalko D; Bourguet W; Balaguer P
Environ Health Perspect; 2011 Sep; 119(9):1227-32. PubMed ID: 21561829
[TBL] [Abstract][Full Text] [Related]
34. Functional profiling of bisphenols for nuclear receptors.
Grimaldi M; Boulahtouf A; Toporova L; Balaguer P
Toxicology; 2019 May; 420():39-45. PubMed ID: 30951782
[TBL] [Abstract][Full Text] [Related]
35. Transcriptomic pathway and benchmark dose analysis of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells.
Peshdary V; Hobbs CA; Maynor T; Shepard K; Gagné R; Williams A; Kuo B; Chepelev N; Recio L; Yauk C; Atlas E
Toxicol In Vitro; 2021 Apr; 72():105097. PubMed ID: 33476716
[TBL] [Abstract][Full Text] [Related]
36. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K
Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627
[TBL] [Abstract][Full Text] [Related]
37. Comparison of thyroid hormone disruption potentials by bisphenols A, S, F, and Z in embryo-larval zebrafish.
Lee S; Kim C; Shin H; Kho Y; Choi K
Chemosphere; 2019 Apr; 221():115-123. PubMed ID: 30639807
[TBL] [Abstract][Full Text] [Related]
38. Endocrine disrupter bisphenol a induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells.
Song KH; Lee K; Choi HS
Endocrinology; 2002 Jun; 143(6):2208-15. PubMed ID: 12021184
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine disruption in animal models due to exposure to bisphenol A analogues.
Rosenfeld CS
Front Neuroendocrinol; 2017 Oct; 47():123-133. PubMed ID: 28801100
[TBL] [Abstract][Full Text] [Related]
40. Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.
Riu A; le Maire A; Grimaldi M; Audebert M; Hillenweck A; Bourguet W; Balaguer P; Zalko D
Toxicol Sci; 2011 Aug; 122(2):372-82. PubMed ID: 21622942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
